ZTS
Zoetis Inc.Compliant · 74/100
Sector: Healthcare · Industry: Drug Manufacturers - General · Data as of 2026-02-12
- Interest income not separately disclosed in filings; assumed immaterial (cash+securities / market cap = 2.7% < 20%).
Screening standard
The evidence
| Test | Figure | Limit | Source |
|---|---|---|---|
| Passed: Business activityBusiness activity is compliant. | compliant | ||
| Passed: Debt vs. market capinterest-bearing debt / market cap = 15.53% (< 33% limit). | 15.53% | < 33.00% | |
| Passed: Interest income vs. revenueInterest income not separately disclosed; assumed immaterial (cash+securities / market cap = 2.7% < 20% threshold). | compliant | ||
| Passed: Cash & interest-bearing assets vs. market cap(cash + interest-bearing securities) / market cap = 2.69% (< 33% limit). | 2.69% | < 33.00% |
Every number, sourced
Figures read directly from SEC EDGAR XBRL facts. Don't trust us — verify.
| Figure | Value | Source |
|---|---|---|
| Total revenueRevenues | $9.5B | |
| Interest-bearing debt4 components | $9.0B | |
| Cash & interest-bearing securities2 components | $1.6B | |
| Total assetsAssets | $15.5B | |
| ReceivablesAccounts receivable net current | $1.6B | |
| Shares outstandingEntity common stock shares outstanding | 419.2M shares | |
| Priceyahoo:24mo-trailing-avg | $138.892 |
Price
Values & Controversies
Separate from the shariah verdict above — always.
No flags. This company isn't on the BNC (Boycott National Committee) priority or divestment lists, or any grassroots BDS-supported campaign we line.